Regulatory

Regulatory  ·  Weekly Digest March 2 to 8
Inotuzumab Ozogamicin receives FDA approval for treatment of Acute Lymphoblastic Leukemia in pediatric patients

Weekly Digest – Mar 2024 Weekly Digest – Mar 2024 06 Mar 2024: Pfizer’s ADC inotuzumab ozogamicin gained FDA approval for use in pediatric patients with acute lymphoblastic leukemia The approval was based on data suggesting that Besponsa led to 42% […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest March 2 to 8
EMA grants dual validation for Daiichi Sankyo and AstraZeneca’s Cancer ADC

Weekly Digest – Mar 2024 Weekly Digest – Mar 2024 04 Mar 2024: EMA grants dual validation for Daiichi Sankyo and AstraZeneca’s Cancer ADC The European Medicines Agency (EMA) has validated the jointly developed TROP2-directed therapy, Dato-DXd, for patients with […]

by Sandhya Ramalingam

Continue Reading